Data from <i>CMTM3</i>, Located at the Critical Tumor Suppressor Locus 16q22.1, Is Silenced by CpG Methylation in Carcinomas and Inhibits Tumor Cell Growth through Inducing Apoptosis

Yu Wang,Jisheng Li,Yan Cui,Ting Li,Ka Man Ng,Hua Geng,Henan Li,Xing-sheng Shu,Hongyu Li,Wei Liu,Bing Luo,Qian Zhang,Tony Shu Kam Mok,Wei Zheng,Xiaoyan Qiu,Gopesh Srivastava,Jun Yu,Joseph J.Y. Sung,Anthony T.C. Chan,Dalong Ma,Qian Tao,Wenling Han

DOI: https://doi.org/10.1158/0008-5472.c.6498665

2023-01-01

Abstract:<div>Abstract<p>Closely located at the tumor suppressor locus 16q22.1, CKLF-like MARVEL transmembrane domain-containing member 3 and 4 (<i>CMTM3</i> and <i>CMTM4</i>) encode two CMTM family proteins, which link chemokines and the transmembrane-4 superfamily. In contrast to the broad expression of both <i>CMTM3</i> and <i>CMTM4</i> in normal human adult tissues, only <i>CMTM3</i> is silenced or down-regulated in common carcinoma (gastric, breast, nasopharyngeal, esophageal, and colon) cell lines and primary tumors. <i>CMTM3</i> methylation was not detected in normal epithelial cell lines and tissues, with weak methylation present in only 5 of 35 (14%) gastric cancer adjacent normal tissues. Furthermore, immunohistochemistry showed that CMTM3 protein was absent in 12 of 35 (34%) gastric and 1 of 2 colorectal tumors, which was well correlated with its methylation status. The silencing of <i>CMTM3</i> is due to aberrant promoter CpG methylation that could be reversed by pharmacologic demethylation. Ectopic expression of <i>CMTM3</i> strongly suppressed the colony formation of carcinoma cell lines. In addition, <i>CMTM3</i> inhibited tumor cell growth and induced apoptosis with caspase-3 activation. Thus, CMTM3 exerts tumor-suppressive functions in tumor cells, with frequent epigenetic inactivation by promoter CpG methylation in common carcinomas. [Cancer Res 2009;69(12):5194–201]</p></div>